Janssen-Cilag G.m.b.H clinical trials

A country office of Johnson & Johnson

The registry lists 11 studies whose lead sponsor is Janssen-Cilag G.m.b.H. 1 are recruiting or about to start. Per ClinicalTrials.gov, last updated Sep 25, 2026.

Studies

Recruiting first, then most recently updated. Showing 11 of 11. All Johnson & Johnson studies →

• A Study to Generate Real-world Evidence of Guselkumab Effectiveness in Inflammatory Bowel Disease in GermanyRecruitingNCT07102368

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• A Study to Compare the Efficacy of Guselkumab to Fumaric Acid Esters for the Treatment of Participants With Moderate to Severe Plaque PsoriasisCompletedNCT02951533Phase 3

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• Human Immunodeficiency Virus (HIV) Postexposure Prophylaxis (PEP) With Darunavir/Ritonavir (DRV/r)CompletedNCT01516970Phase 3

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• A Study of Bortezomib as Consolidation Therapy in Patients With Multiple MyelomaCompletedNCT00416273Phase 3

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• Consolidation Therapy With Bortezomib in Elderly Patients With Multiple MyelomaCompletedNCT00416208Phase 3

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• A Study of Bortezomib, Cyclophosphamide, and Dexamethasone in Patients With Untreated Multiple Myeloma and Planned for a High Dose ChemotherapyCompletedNCT00833560Phase 2

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• Study of Bortezomib and Dexamethasone With or Without Cyclophosphamide in Patients With Relapsed or Not Controllable Multiple MyelomaCompletedNCT00813150Phase 3

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• Long-term Use of Galantamine Versus Nootropics (Memory Enhancing Drugs) in Patients With Alzheimer's Dementia Under Conditions of Daily RoutineCompletedNCT01009476

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• An Efficacy and Tolerability Study of Bortezomib in Combination With Rituximab Standard Therapy in Participants With Relapsed or Refractory Follicular LymphomaTerminatedNCT01902862Phase 2

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• A Positron-Emission-Tomography (PET) Study to Measure the Blockade of Dopamine Receptors (D2) in Specific Areas of the Brain in Relation to the Plasma Concentrations of Paliperidone Extended Release (ER) and Oral Risperidone in Schizophrenia Patients and Healthy ControlsTerminatedNCT00934635Phase 4

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H

• A Study to Evaluate the Safety and Tolerability of Fentanyl Iontophoretic Transdermal System (Fentanyl-ITS) in the Management of Post-Surgery PainTerminatedNCT01804673Phase 4

  Sponsor listed in the registry: Janssen-Cilag G.m.b.H